These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19822806)

  • 21. Gender and effects of a common genetic variant in the NOS1 regulator NOS1AP on cardiac repolarization in 3761 individuals from two independent populations.
    Tobin MD; Kähönen M; Braund P; Nieminen T; Hajat C; Tomaszewski M; Viik J; Lehtinen R; Ng GA; Macfarlane PW; Burton PR; Lehtimäki T; Samani NJ
    Int J Epidemiol; 2008 Oct; 37(5):1132-41. PubMed ID: 18511491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AKAP9 is a genetic modifier of congenital long-QT syndrome type 1.
    de Villiers CP; van der Merwe L; Crotti L; Goosen A; George AL; Schwartz PJ; Brink PA; Moolman-Smook JC; Corfield VA
    Circ Cardiovasc Genet; 2014 Oct; 7(5):599-606. PubMed ID: 25087618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KCNE1 D85N polymorphism--a sex-specific modifier in type 1 long QT syndrome?
    Lahtinen AM; Marjamaa A; Swan H; Kontula K
    BMC Med Genet; 2011 Jan; 12():11. PubMed ID: 21244686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. QT interval prolongation and risk for cardiac events in genotyped LQTS-index children.
    Wedekind H; Burde D; Zumhagen S; Debus V; Burkhardtsmaier G; Mönnig G; Breithardt G; Schulze-Bahr E
    Eur J Pediatr; 2009 Sep; 168(9):1107-15. PubMed ID: 19101729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome.
    Schwartz PJ; Vanoli E; Crotti L; Spazzolini C; Ferrandi C; Goosen A; Hedley P; Heradien M; Bacchini S; Turco A; La Rovere MT; Bartoli A; George AL; Brink PA
    J Am Coll Cardiol; 2008 Mar; 51(9):920-9. PubMed ID: 18308161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval.
    Kapoor A; Sekar RB; Hansen NF; Fox-Talbot K; Morley M; Pihur V; Chatterjee S; Brandimarto J; Moravec CS; Pulit SL; ; Pfeufer A; Mullikin J; Ross M; Green ED; Bentley D; Newton-Cheh C; Boerwinkle E; Tomaselli GF; Cappola TP; Arking DE; Halushka MK; Chakravarti A
    Am J Hum Genet; 2014 Jun; 94(6):854-69. PubMed ID: 24857694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics of 30 Czech families with long QT syndrome and KCNQ1 and KCNH2 gene mutations: importance of exercise testing.
    Andrsova I; Novotny T; Kadlecova J; Bittnerova A; Vit P; Florianova A; Sisakova M; Gaillyova R; Manouskova L; Spinar J
    J Electrocardiol; 2012; 45(6):746-51. PubMed ID: 22727609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis, management and therapeutic strategies for congenital long QT syndrome.
    Wilde AAM; Amin AS; Postema PG
    Heart; 2022 Mar; 108(5):332-338. PubMed ID: 34039680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The common long-QT syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification.
    Crotti L; Spazzolini C; Schwartz PJ; Shimizu W; Denjoy I; Schulze-Bahr E; Zaklyazminskaya EV; Swan H; Ackerman MJ; Moss AJ; Wilde AA; Horie M; Brink PA; Insolia R; De Ferrari GM; Crimi G
    Circulation; 2007 Nov; 116(21):2366-75. PubMed ID: 17984373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.
    Goldenberg I; Horr S; Moss AJ; Lopes CM; Barsheshet A; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Platonov PG; Priori SG; Qi M; Schwartz PJ; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Zhang L
    J Am Coll Cardiol; 2011 Jan; 57(1):51-9. PubMed ID: 21185501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variants and effect modifiers of QT interval prolongation in patients with sickle cell disease.
    Zhang M; Hillegass WB; Yu X; Majumdar S; Daryl Pollard J; Jackson E; Knudson J; Wolfe D; Kato GJ; Maher JF; Mei H
    Gene; 2024 Jan; 890():147824. PubMed ID: 37741592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Letter by Herring and Paterson regarding article, "Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study".
    Herring N; Paterson DJ
    Circulation; 2007 Dec; 116(24):e564; author reply e565. PubMed ID: 18071084
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on the Diagnosis and Management of Familial Long QT Syndrome.
    Waddell-Smith KE; Skinner JR;
    Heart Lung Circ; 2016 Aug; 25(8):769-76. PubMed ID: 27262388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese Patients.
    Shimizu W; Makimoto H; Yamagata K; Kamakura T; Wada M; Miyamoto K; Inoue-Yamada Y; Okamura H; Ishibashi K; Noda T; Nagase S; Miyazaki A; Sakaguchi H; Shiraishi I; Makiyama T; Ohno S; Itoh H; Watanabe H; Hayashi K; Yamagishi M; Morita H; Yoshinaga M; Aizawa Y; Kusano K; Miyamoto Y; Kamakura S; Yasuda S; Ogawa H; Tanaka T; Sumitomo N; Hagiwara N; Fukuda K; Ogawa S; Aizawa Y; Makita N; Ohe T; Horie M; Aiba T
    JAMA Cardiol; 2019 Mar; 4(3):246-254. PubMed ID: 30758498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible over-expression of cardiac Nos1ap causes short QT syndrome in transgenic mice.
    Jänsch M; Lubomirov LT; Trum M; Williams T; Schmitt J; Schuh K; Qadri F; Maier LS; Bader M; Ritter O
    FEBS Open Bio; 2023 Jan; 13(1):118-132. PubMed ID: 36352324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome.
    Duchatelet S; Crotti L; Peat RA; Denjoy I; Itoh H; Berthet M; Ohno S; Fressart V; Monti MC; Crocamo C; Pedrazzini M; Dagradi F; Vicentini A; Klug D; Brink PA; Goosen A; Swan H; Toivonen L; Lahtinen AM; Kontula K; Shimizu W; Horie M; George AL; Trégouët DA; Guicheney P; Schwartz PJ
    Circ Cardiovasc Genet; 2013 Aug; 6(4):354-61. PubMed ID: 23856471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relation of increased short-term variability of QT interval to congenital long-QT syndrome.
    Hinterseer M; Beckmann BM; Thomsen MB; Pfeufer A; Dalla Pozza R; Loeff M; Netz H; Steinbeck G; Vos MA; Kääb S
    Am J Cardiol; 2009 May; 103(9):1244-8. PubMed ID: 19406266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a common variant at the NOS1AP locus strongly associated to QT-interval duration.
    Eijgelsheim M; Aarnoudse AL; Rivadeneira F; Kors JA; Witteman JC; Hofman A; van Duijn CM; Uitterlinden AG; Stricker BH
    Hum Mol Genet; 2009 Jan; 18(2):347-57. PubMed ID: 18927126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KCNQ1 mutations in patients with a family history of lethal cardiac arrhythmias and sudden death.
    Chen S; Zhang L; Bryant RM; Vincent GM; Flippin M; Lee JC; Brown E; Zimmerman F; Rozich R; Szafranski P; Oberti C; Sterba R; Marangi D; Tchou PJ; Chung MK; Wang Q
    Clin Genet; 2003 Apr; 63(4):273-82. PubMed ID: 12702160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arrhythmia phenotype during fetal life suggests long-QT syndrome genotype: risk stratification of perinatal long-QT syndrome.
    Cuneo BF; Etheridge SP; Horigome H; Sallee D; Moon-Grady A; Weng HY; Ackerman MJ; Benson DW
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):946-51. PubMed ID: 23995044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.